Evidence map›Paper›PMID 35886058›Full record

ArticleGenes2022

Atypical, Composite, or Blended Phenotypes: How Different Molecular Mechanisms Could Associate in Double-Diagnosed Patients.

Erica Rosina, Lidia Pezzani, Laura Pezzoli, Daniela Marchetti, Matteo Bellini, Alba Pilotta, Olga Calabrese, Emanuele Nicastro, Francesco Cirillo, Anna Cereda and 3 more

Open access · goldAbstract read
In one paragraph

Article in Genes, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
5.2field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Navigating an Uninformative Genomic Test Result: A Practical Guide.Journal of paediatrics and child health · 2025
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 1 country.

Erica RosinaLaboratory of Medical Genetics, ASST Papa Giovanni XXIII, 24127 Bergamo, Italy.
Lidia PezzaniPaediatric Unit, ASST Papa Giovanni XXIII, 24127 Bergamo, Italy.
Laura PezzoliLaboratory of Medical Genetics, ASST Papa Giovanni XXIII, 24127 Bergamo, Italy.ORCID 0000-0002-8111-563X
Daniela MarchettiLaboratory of Medical Genetics, ASST Papa Giovanni XXIII, 24127 Bergamo, Italy.ORCID 0000-0002-5189-0061
Matteo BelliniLaboratory of Medical Genetics, ASST Papa Giovanni XXIII, 24127 Bergamo, Italy.
Alba PilottaAuxo-Endocrinology, Diabetology and Medical Genetic Unit, Department of Paediatrics, ASST Spedali Civili, 25123 Brescia, Italy.
Olga CalabreseMedical Genetics Unit, Azienda Ospedaliera Universitaria di Modena, 41125 Modena, Italy.ORCID 0000-0001-8947-5990
Emanuele NicastroPaediatric Unit, ASST Papa Giovanni XXIII, 24127 Bergamo, Italy.ORCID 0000-0002-4518-9375
Francesco CirilloPediatric Hepatology and Paediatric Liver Transplantation, Istituto Mediterraneo per i Trapianti e Terapie ad Alta Specializzazione, 90127 Palermo, Italy.
Anna CeredaPaediatric Unit, ASST Papa Giovanni XXIII, 24127 Bergamo, Italy.
Agnese ScatignoPaediatric Unit, ASST Papa Giovanni XXIII, 24127 Bergamo, Italy.
Donatella MilaniFondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, 20122 Milano, Italy.ORCID 0000-0002-3087-8514
Maria IasconeLaboratory of Medical Genetics, ASST Papa Giovanni XXIII, 24127 Bergamo, Italy.ORCID 0000-0002-4707-212X
Ospedale Papa Giovanni XXIII · ITFondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico · ITAzienda Ospedaliero-Universitaria di Modena · ITAzienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia · ITIstituto Mediterraneo per i Trapianti e Terapie ad Alta Specializzazione · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the last few years, trio-Whole Exome Sequencing (WES) analysis has revolutionized the diagnostic process for patients with rare genetic syndromes, demonstrating its potential even in non-specific clinical pictures and in atypical presentations of known diseases. Multiple disorders in a single patient have been estimated to occur in approximately 2-7.5% of diagnosed cases, with higher frequency in consanguineous families. Here, we report the clinical and molecular characterisation of eight illustrative patients for whom trio-WES allowed for identifing more than one genetic condition. Double homozygosity represented the causal mechanism in only half of them, whereas the other half showed peculiar multilocus combinations. The paper takes into consideration difficulties and learned lessons from our experience and therefore supports the powerful role of wide analyses for ascertaining multiple genetic diseases in complex patients, especially when a clinical suspicion could account for the majority of clinical signs. It finally makes clear how a patient's "deep phenotyping" might not be sufficient to suggest the presence of multiple genetic diagnoses but remains essential to validate an unexpected multilocus result from genetic tests.

Indexed as

ExomeGenetic TestingFamilyHomozygotePhenotypecomposite phenotypedeep phenotypingdouble diagnosistrio-WES

Identifiers

PMID35886058
PMCPMC9319862
OpenAlexW4286219549

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.